{"database": "lobbying", "table": "lobbying_activities", "rows": [[1631905, "5189c4c7-0809-4340-9bd6-749a5aa2b71f", "Q4", "NOSSAMAN LLP", 29846, "AMERISOURCEBERGEN CORPORATION (FORMERLY \"AMERISOURCEBERGEN SPECIALTY GROUP\")", 2014, "fourth_quarter", "PHA", "H.R.800 & S.806 Medicare Prompt Pay Discount Exclusion (H.R.800 & S.806), legislation to ensure more appropriate general payment amount for drugs & biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Cancer Patient Protection Act of 2013 (H.R.1416), legislation to exclude cancer drugs from sequestration cuts. Prescription Drug Abuse Legislation (H.R.1919, H.R.3204, S.957 & S.959)", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2015-01-20T09:24:38.203000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1631905"], "units": {}, "query_ms": 9.962223004549742, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}